Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Genetics|May 8, 2018
TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 ProductionXiu-Guo Han, Hui-Min Mo, Xu-Qiang Liu, et al.
The Journal of Physical Chemistry Letters|February 27, 2024
Artificial Neural Synapses Based on Microfluidic Memristors Prepared by Capillary Tubes and Ionic LiquidTong-Tong Guo, Jian-Biao Chen, Chun-Yan Yang, et al.
Journal of Neuroinflammation|April 9, 2014
Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injuryZai-Wang Li, Ji-Jun Li, Lan Wang, et al.
Food Science & Nutrition|July 17, 2023
Protective effect of mussel polysaccharide on cyclophosphamide-induced intestinal oxidative stress injury via Nrf2-Keap1 signaling pathwayZhen-Lei Zhao, Xiao-Gang Xu, Yun-Chuang Chang, et al.
Acta Pharmacologica Sinica|March 15, 2016
Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathwaysXu-qiang Nie, Huai-hong Chen, Jian-yong Zhang, et al.
British Journal of Cancer|September 5, 2025
Efficacy and safety of induction immunotherapy plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a meta-analysisKun-Peng Wu, Xu-Qiang Luo, Qing-Qing Li, et al.
Translational Oncology|November 5, 2023
Hsa_circ_0020134 promotes liver metastasis of colorectal cancer through the miR-183-5p-PFN2-TGF-β/Smad axisJin-Hao Yu, Jia-Nan Tan, Guang-Yu Zhong, et al.
Med (New York, N.Y.)|February 7, 2026
Incidence and spectrum of immune-related adverse events in nasopharyngeal carcinoma patients treated with immune checkpoint inhibitorsKun-Peng Wu, Xu-Qiang Luo, Pei-Xin Tan, et al.
Annals of Medicine|January 21, 2025
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVaKun-Peng Wu, Qing-Qing Li, Xu-Qiang Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summaryShakun M Malik, Ke Liu, Xu Qiang, et al.
Pageof 8